pistoia alliance debates: clinical trials and wearables, 21st jan 2016
TRANSCRIPT
![Page 1: Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016](https://reader033.vdocuments.us/reader033/viewer/2022052705/58d025c11a28ab97708b6647/html5/thumbnails/1.jpg)
2 May 2023
Clinical trials and wearablesA Pistoia Alliance Debates webinar
Chaired by Richard Lingard, Dotmatics
Partner logo if required
![Page 2: Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016](https://reader033.vdocuments.us/reader033/viewer/2022052705/58d025c11a28ab97708b6647/html5/thumbnails/2.jpg)
This webinar is being recorded
Partner logo if required
![Page 3: Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016](https://reader033.vdocuments.us/reader033/viewer/2022052705/58d025c11a28ab97708b6647/html5/thumbnails/3.jpg)
© P
istoi
a Al
lianc
e
32 May 2023
Panelists
Pistoia Alliance Debates: Clinical trials and wearables
Richard Lingard, Head of Commercial Operations, Dotmatics has a chemistry background and has been working in the life sciences industry for over two decades, focusing on the business side of drug discovery technology and services. Richard has enjoyed a number of international commercial roles at research supporting organisations: Thomson Reuters and Biovia, as well as research organisations like Argenta Discovery and Merck & Co Inc. As a Management & Chemical and Sciences graduate of UMIST he is still pleased to be using his degree in everyday working life.
Marie Mc Carthy MSc, MBA. Director Product Innovation, is part of the multidisciplinary Innovation Team at ICON PLC. She has specific responsibility for developing solutions in the direct to patient paradigm. Her previous role was that of EU Sales and Marketing Manager with Philips Respironics, building awareness of the value of Actigraphy endpoints among Clinicians and Researchers.
Christian Gossens is leading the Early Development Workflow team in Roche’s Research and Early Development Informatics organization. His team covers workflows in Proteomics and Genetics & Genomics over Clinical Pharmacology to Clinical Operations. He is currently focusing to drive innovation with digital tools for patient and investigator recruitment and engagement.
Matt Jones has over 16 years' experience of working in Research and development and informatics groups within the Pharmaceutical industry. Matt joined Glaxo Wellcome/GSK in 1998 as a scientific software engineer after completing his PhD in synthetic organic chemistry at the University of Bath. He moved through technical leadership, project and programme management roles before leaving in 2014 to join Tessella. Matt is currently helping lead and drive the Tessella advanced analytics strategy, to bring our cross domain experience to bear on the challenges that life science and modern pharma faces.
Partner logo if required
![Page 4: Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016](https://reader033.vdocuments.us/reader033/viewer/2022052705/58d025c11a28ab97708b6647/html5/thumbnails/4.jpg)
dotmaticsknowledge solutions
. . .
Clinical trials and wearablesRichard LingardSVP Global Commercial Operations
Dotmatics Ltd
![Page 5: Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016](https://reader033.vdocuments.us/reader033/viewer/2022052705/58d025c11a28ab97708b6647/html5/thumbnails/5.jpg)
dotmaticsknowledge solutions
.. .
• Consumer wearables prevalent – Low cost – him availability– High compliance rate – people want them
• Data capture ongoing – Adapt to clinical trials– App usage/ Custom App
• Advantages/ Hurdles– Cost, compliance, monitoring– FDA / EMA approval
Consumer wearables for clinical trials
![Page 6: Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016](https://reader033.vdocuments.us/reader033/viewer/2022052705/58d025c11a28ab97708b6647/html5/thumbnails/6.jpg)
dotmaticsknowledge solutions
.. .
• Butterfly effect - wearables- Clinical trials changed forever?
Disruptive
![Page 7: Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016](https://reader033.vdocuments.us/reader033/viewer/2022052705/58d025c11a28ab97708b6647/html5/thumbnails/7.jpg)
Wearables and Clinical Trials
27th Jan 2016
Name: Marie Mc Carthy
Title: Director Product Innovation
![Page 8: Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016](https://reader033.vdocuments.us/reader033/viewer/2022052705/58d025c11a28ab97708b6647/html5/thumbnails/8.jpg)
Wearables
By 2019 245 million wearable devices sold CCS Insights latest Wearable Tech
![Page 9: Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016](https://reader033.vdocuments.us/reader033/viewer/2022052705/58d025c11a28ab97708b6647/html5/thumbnails/9.jpg)
Value of Wearables in Clinical Trials
Trial of the Future
Patient EngagementPatient BurdenReal Time DataReal world DataNew Data
![Page 10: Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016](https://reader033.vdocuments.us/reader033/viewer/2022052705/58d025c11a28ab97708b6647/html5/thumbnails/10.jpg)
Considerations
Clinical Question
Fit for Purpose
Device/Vendor
Data Transfer Data Management
![Page 11: Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016](https://reader033.vdocuments.us/reader033/viewer/2022052705/58d025c11a28ab97708b6647/html5/thumbnails/11.jpg)
Wearables are so 1970’s !
Outcome Measures
![Page 12: Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016](https://reader033.vdocuments.us/reader033/viewer/2022052705/58d025c11a28ab97708b6647/html5/thumbnails/12.jpg)
12
80% CNS
90 Trials
82% 1°and 2°endpoint
![Page 13: Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016](https://reader033.vdocuments.us/reader033/viewer/2022052705/58d025c11a28ab97708b6647/html5/thumbnails/13.jpg)
Bringing remote patient monitoring into clinical trialsA Parkinson’s Disease case study in Roche pRED
Christian Gossens, PhD, MBA, Global Head Early Development WorkflowsPistoia Alliance Debates “Clinical trials and wearables”, 21 January 2016
![Page 14: Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016](https://reader033.vdocuments.us/reader033/viewer/2022052705/58d025c11a28ab97708b6647/html5/thumbnails/14.jpg)
Smartphones are (nearly) everywhereBut not yet in clinical trials!Disruptive consumer adoption…
… and an opportunity for drug development?
14Source: Spiegel Online
![Page 15: Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016](https://reader033.vdocuments.us/reader033/viewer/2022052705/58d025c11a28ab97708b6647/html5/thumbnails/15.jpg)
Disruptive adoption of smartphones Opens a new space of opportunies for clinical research
15
![Page 16: Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016](https://reader033.vdocuments.us/reader033/viewer/2022052705/58d025c11a28ab97708b6647/html5/thumbnails/16.jpg)
How is the patient doing outside the clinic?Measuring disease progression continuously
16
![Page 17: Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016](https://reader033.vdocuments.us/reader033/viewer/2022052705/58d025c11a28ab97708b6647/html5/thumbnails/17.jpg)
Towards prediction of today’s clinical gold standard using smartphone data
17
Sensor data
UPDRS*Clinical parameter
of interest
Train model using Machine
Learning algorithm on UPDRS*
1.
Sensor data
2. Predict UPDRS*
using model developed above
* UPDRS: Unified Parkinson Disease Rating Scale
![Page 18: Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016](https://reader033.vdocuments.us/reader033/viewer/2022052705/58d025c11a28ab97708b6647/html5/thumbnails/18.jpg)
Remote patient monitoring in a clinical trialFour-fold motivation for Roche
Get app workflow into the clinic
Ensure uptake and adherence
Use active tests to track disease progression
Develop frictionless monitoring
18
![Page 19: Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016](https://reader033.vdocuments.us/reader033/viewer/2022052705/58d025c11a28ab97708b6647/html5/thumbnails/19.jpg)
End to end workflow established in clinical trialFrom smartphone distribution through to data analysis
Automatic encrypted data upload via WIFI
![Page 20: Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016](https://reader033.vdocuments.us/reader033/viewer/2022052705/58d025c11a28ab97708b6647/html5/thumbnails/20.jpg)
The Roche Parkinson’s Disease mobile appThe patient’s daily routineActive Test (in the morning)
Dexterity test
Passive Monitoring(throughout the day)
Data upload
![Page 21: Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016](https://reader033.vdocuments.us/reader033/viewer/2022052705/58d025c11a28ab97708b6647/html5/thumbnails/21.jpg)
Smartphone sensors provide rich raw dataData read out for Active Tests & Passive Monitoring
21
Y
X
Z
Main data from magnetometer, accelerometer and gyroscope:• Recordings in three directions• Sampling rate: ~60Hz
Other data • Touch data• Voice recording (only during
30s voice tests)• Light• Location (GPS, Wifi)• Battery level
![Page 22: Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016](https://reader033.vdocuments.us/reader033/viewer/2022052705/58d025c11a28ab97708b6647/html5/thumbnails/22.jpg)
Many building blocks must be fit together to deliver a scientifically meaningful “tool”From technology, workflows through to data analysis
22
![Page 23: Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016](https://reader033.vdocuments.us/reader033/viewer/2022052705/58d025c11a28ab97708b6647/html5/thumbnails/23.jpg)
A cross-functional team is requiredFrom legal through to clinical operations
![Page 24: Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016](https://reader033.vdocuments.us/reader033/viewer/2022052705/58d025c11a28ab97708b6647/html5/thumbnails/24.jpg)
Remote patient monitoring in a clinical trialFour-fold motivation for Roche
Get app workflow into the clinic
Ensure uptake and adherence
Use active tests to track disease progression
Develop frictionless monitoring
24
![Page 25: Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016](https://reader033.vdocuments.us/reader033/viewer/2022052705/58d025c11a28ab97708b6647/html5/thumbnails/25.jpg)
“Big” data is being collected as we speakOver 1500 active tests &140 GB of passive monitoring data
25
Time
GB
sens
or d
ata
colle
cted
by
pati
ents
May ‘15
December ‘15
Colours: data accumulated by different patients
0
140
![Page 26: Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016](https://reader033.vdocuments.us/reader033/viewer/2022052705/58d025c11a28ab97708b6647/html5/thumbnails/26.jpg)
Adherence is supported with proactive monitoringExample: replacing fast-draining batteries
Batte
ry d
rain
age
Time
How battery drainage per hour gets worse over time for the selected
smartphone
26
Batte
ry d
rain
age
Smartphones used by patients
Battery drainage for smartphones in trial
Screening Middle of the trial
![Page 27: Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016](https://reader033.vdocuments.us/reader033/viewer/2022052705/58d025c11a28ab97708b6647/html5/thumbnails/27.jpg)
Remote patient monitoring in a clinical trialFour-fold motivation for Roche
Get app workflow into the clinic
Ensure uptake and adherence
Use active tests to track disease progression
Develop frictionless monitoring
27
In progress
![Page 28: Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016](https://reader033.vdocuments.us/reader033/viewer/2022052705/58d025c11a28ab97708b6647/html5/thumbnails/28.jpg)
Automatic data cleaning is a prerequisite An example from the voice test, applied to over 1500 records
For automated data cleaning, the sound waves are segmented to remove:• Phone beep before first
phonation• Anything after first
phonation (quiet time, breathing)
Ampl
itude
Pitc
h (H
z)
The “useful” segmentInitial
beep
Voice amplitude and pitch
![Page 29: Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016](https://reader033.vdocuments.us/reader033/viewer/2022052705/58d025c11a28ab97708b6647/html5/thumbnails/29.jpg)
Pow
er o
n sm
artp
hone
(am
ount
of
ener
gy a
t di
ffer
ent
freq
uenc
ies)
Frequency (Hz)
Postural tremor power spectrum
HzDeuschl et al (1998). Movement Disorders
Longitudinal is key: Patient tremor severity varies from day to day (on/off)
No visible tremor
Plainly visible tremor
Frequency (Hz)29
Smartphone sensors compete with high cost, stationary clinical equipmentFirst results in line with medical literature
![Page 30: Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016](https://reader033.vdocuments.us/reader033/viewer/2022052705/58d025c11a28ab97708b6647/html5/thumbnails/30.jpg)
Roche is paving the way for “Digital Biomarkers”We have developed the capabilities and a scalable approach
Technology & workflows
Data analysis
Program management
30
![Page 31: Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016](https://reader033.vdocuments.us/reader033/viewer/2022052705/58d025c11a28ab97708b6647/html5/thumbnails/31.jpg)
Learn more on Roche.com or YouTube“Roche app measures Parkinson's disease fluctuations”
31
Take a look: https://www.youtube.com/watch?v=d2Ofu-Bf_p8
![Page 32: Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016](https://reader033.vdocuments.us/reader033/viewer/2022052705/58d025c11a28ab97708b6647/html5/thumbnails/32.jpg)
Doing now what patients need next
![Page 33: Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016](https://reader033.vdocuments.us/reader033/viewer/2022052705/58d025c11a28ab97708b6647/html5/thumbnails/33.jpg)
Matt Jones – Pistoia – Jan 2016
Wearables – Data standards for clinical applications
![Page 34: Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016](https://reader033.vdocuments.us/reader033/viewer/2022052705/58d025c11a28ab97708b6647/html5/thumbnails/34.jpg)
Rise of the consumer wearable
![Page 35: Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016](https://reader033.vdocuments.us/reader033/viewer/2022052705/58d025c11a28ab97708b6647/html5/thumbnails/35.jpg)
![Page 36: Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016](https://reader033.vdocuments.us/reader033/viewer/2022052705/58d025c11a28ab97708b6647/html5/thumbnails/36.jpg)
![Page 37: Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016](https://reader033.vdocuments.us/reader033/viewer/2022052705/58d025c11a28ab97708b6647/html5/thumbnails/37.jpg)
Pistoia IP3 Proposalhttps://main.qmarkets.org/live/pistoia/node/1588
Please do• Join the Interest Group• Ask any questions
Remember• There’s no formal
commitment made in joining the group!
• But a great opportunity to learn and share information
![Page 38: Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016](https://reader033.vdocuments.us/reader033/viewer/2022052705/58d025c11a28ab97708b6647/html5/thumbnails/38.jpg)
Discussion and Audience Q&A
Partner logo if required
![Page 39: Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016](https://reader033.vdocuments.us/reader033/viewer/2022052705/58d025c11a28ab97708b6647/html5/thumbnails/39.jpg)
Smart Glasses, Smart ScientistsThursday 25th Feb, 11am-midday EST
Register at https://attendee.gotowebinar.com/register/7916985468511785729
Partner logo if required